Skip to content

Teladoc Health

US · TDOC #3241 by market cap Listed 2015
7.45 -0.34 -4.36%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:44

Price chart

Pre-market 7.65 -1.80%
After-hours 7.35 -1.34%
Overnight 7.70 -1.16%
9.725.527.452026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on TDOC?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +12.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 17.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days E → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall C

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth B+

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 1.7% Better than 33%
Free cash flow CAGR (3Y) 102.5% Better than 93%
Profitability C-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 69.5% Better than 82%
Operating margin -6.5% Better than 16%
Net margin -7.9% Better than 17%
Return on equity -13.9% Better than 18%
Return on invested capital -7.8% Better than 19%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 16.6% Better than 95%
6-month return 13.4% Better than 76%
12-month return (ex latest month) -8.9% Better than 24%
Distance below 52-week high 24.6% Better than 51%
Financial Health C-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.8x Better than 70%
Debt to assets 36.4% Better than 31%
Interest coverage -10.9x Better than 13%
Analyst View C

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 33.3% Better than 18%
Upside to average target 26.7% Better than 44%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -15.34%
1M +19.97%
3M +14.79%
6M +14.97%
YTD +6.43%
1Y +10.21%
3Y -57.36%
5Y -93.63%

Key statistics

Price & volume

Prev close
7.79
Open
7.68
Day range
7.40 - 7.88
Avg price
7.56
Volume
4.71M
Turnover
35.57M
Amplitude
6.10%
52-week range
4.40 - 9.89

Valuation

P/E
-6.54
P/E (TTM)
-8.66
P/B
1.05
EPS
-1.14
Net profit
-207.81M
Net assets
1.29B

Share structure

Market cap
1.36B
Float cap
1.35B
Shares out
182.29M
Float shares
181.07M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2015-07-01
52-week range 56% of range
4.40 9.89

24.6% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+4.98M net over the window

Short interest

Shares short
32.19M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Teladoc Health (TDOC)?

Teladoc Health last traded at 7.45. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Teladoc Health's market cap?

About 1.36B.

What is the P/E ratio of Teladoc Health?

The trailing twelve-month P/E is -8.66. The Valuation tab shows it against the stock's own five-year range.

Does Teladoc Health pay a dividend?

Teladoc Health does not currently pay a regular dividend.

Is Teladoc Health a buy according to analysts?

The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 9.44, which implies 26.7% upside from the current price. This is not investment advice.

What is Teladoc Health's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Teladoc Health a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:44:00 · For reference only, not investment advice and not tailored to your situation.

Teladoc Health discussion 0 comments

Add a comment